Phibro Animal Health (PAHC) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. WDC
2. DECK
3. RNG
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. BMY
10. NDAQ

Go back to Phibro Animal Health (PAHC) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 Guidance

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

February 4, 2026 4:25 PM EST

TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026.

Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024):

Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Diluted earnings per share of $0.67, an increase of $0.59 Adjusted EBITDA of $68.1 million, an increase of $19.9 million, or 41% Adjusted... More